|
STK3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.945000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.764200E-01 |
| Normal-vs-Stage2 |
7.172800E-01 |
| Normal-vs-Stage3 |
4.706800E-01 |
| Normal-vs-Stage4 |
8.948200E-01 |
| Stage1-vs-Stage2 |
9.280000E-01 |
| Stage1-vs-Stage3 |
1.830390E-01 |
| Stage1-vs-Stage4 |
6.475000E-01 |
| Stage2-vs-Stage3 |
3.091800E-01 |
| Stage2-vs-Stage4 |
6.511000E-01 |
| Stage3-vs-Stage4 |
5.833400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.420200E-01 |
| Normal-vs-AfricanAmerican |
4.018500E-02 |
| Normal-vs-Asian |
8.946600E-01 |
| Caucasian-vs-AfricanAmerican |
4.704000E-02 |
| Caucasian-vs-Asian |
9.361800E-01 |
| AfricanAmerican-vs-Asian |
5.143900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.129200E-01 |
| Normal-vs-Female |
6.420400E-01 |
| Male-vs-Female |
1.622240E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.147600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.799000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.136400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.012800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.147410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.130200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.085400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.320000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.614600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.355400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.203000E-01 |
| Classical-VS-Follicular |
9.295000E-01 |
| Classical-VS-Other |
4.315400E-01 |
| Classical-VS-Normal |
6.069400E-01 |
| Tall-VS-Follicular |
3.855600E-01 |
| Tall-VS-Other |
6.567000E-01 |
| Tall-VS-Normal |
6.356600E-01 |
| Follicular-VS-Other |
4.815600E-01 |
| Follicular-VS-Normal |
6.480800E-01 |
| Other-VS-Normal |
4.683200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.435800E-01 |
| Normal-vs-N1 |
5.117200E-01 |
| N0-vs-N1 |
6.085600E-01 |
|
|
